Reported Reactions

Devices › Device types

FDA product code MNQ · class 3 · Unknown

Stimulator, hypoglossal nerve, implanted, apnea: medical device reports filed with FDA

3,571 reports carry this product code, 2014–2026; 5 brands with a page.

3,571
reports with this product code
0% of all MAUDE reports
1,025
reports, 12 months to August 2026
882 in the 12 months before
4.5%
classified as malfunction
62.3% across all reports
0.1%
classified as death, as reported
0.9% across all reports

Product code MNQ is FDA's classification for "Stimulator, hypoglossal nerve, implanted, apnea" (unknown panel), a class 3 device. 3,571 medical device reports carry this product code, 0% of the MAUDE database, from July 2014 to August 2026.

1,025 reports arrived in the 12 months to August 2026, up 16% from 882 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (95.3%), malfunction (4.5%) and death (0.1%). 5 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Inspire Model 3028 IPG1,4372980.3%0.3%
Inspire Model 4063 Stimulation Lead1,3134260%0.3%
Inspire Model 4340 Respiratory Sensing Lead272360%29.8%
Inspire V IPG Model 31501661630%0%
Dexcom G715830.1%51.6%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Inspire Medical Systems3,48097.5%
Houston20.1%
Dexcom10%
Livanova USA10%
Medtronic Puerto Rico Operations Juncos10%

Reports by month, five years

053105Sep 2021: 16Oct 2021: 38Nov 2021: 31Dec 2021: 222022Jan 2022: 17Feb 2022: 16Mar 2022: 24Apr 2022: 5May 2022: 32Jun 2022: 21Jul 2022: 21Aug 2022: 19Sep 2022: 20Oct 2022: 22Nov 2022: 44Dec 2022: 422023Jan 2023: 29Feb 2023: 22Mar 2023: 48Apr 2023: 39May 2023: 31Jun 2023: 31Jul 2023: 27Aug 2023: 46Sep 2023: 47Oct 2023: 34Nov 2023: 44Dec 2023: 622024Jan 2024: 59Feb 2024: 44Mar 2024: 48Apr 2024: 64May 2024: 68Jun 2024: 46Jul 2024: 62Aug 2024: 49Sep 2024: 53Oct 2024: 56Nov 2024: 66Dec 2024: 822025Jan 2025: 56Feb 2025: 72Mar 2025: 68Apr 2025: 76May 2025: 96Jun 2025: 104Jul 2025: 69Aug 2025: 84Sep 2025: 80Oct 2025: 77Nov 2025: 100Dec 2025: 782026Jan 2026: 105Feb 2026: 89Mar 2026: 94Apr 2026: 88May 2026: 74Jun 2026: 86Jul 2026: 69Aug 2026: 85

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.1%4
Injury95.3%3,404
Malfunction4.5%161
Other0.1%2
Not given0%0

Who filed

Manufacturer report95%3,391
Voluntary report4.5%159
User facility report0%0
Distributor report0%0
Not given0.6%21

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Migrationthe device moved from where it was placed2156%
Migration or expulsion of device1664.6%
Device sensing problem1183.3%
Expulsion511.4%
Malposition of device351%
Failure to deliver energy180.5%
Inappropriate/inadequate shock/stimulation180.5%
Detachment of device or device componentpart of the device came off170.5%
Material twisted/bent170.5%
Insufficient device problem information160.4%
Therapeutic or diagnostic output failure140.4%
Patient device interaction problem130.4%
Improper or incorrect procedure or method110.3%
Positioning problem90.3%
Defective devicethe device was defective80.2%
Device dislodged or dislocated80.2%
Material split, cut or torn80.2%
Impedance problem70.2%
Electrical /electronic property probleman electrical or electronic problem50.1%
Self-activation or keying50.1%

Questions about stimulator, hypoglossal nerve, implanted, apnea reports

What is product code MNQ?

FDA's classification code for "Stimulator, hypoglossal nerve, implanted, apnea", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

3,571 reports through August 2026, 1,025 of them in the latest 12 months.

Which brands appear most often?

Inspire Model 3028 IPG (1,437), Inspire Model 4063 Stimulation Lead (1,313), Inspire Model 4340 Respiratory Sensing Lead (272), Inspire V IPG Model 3150 (166) and Dexcom G7 (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.